ArticleCell biochemistry and biophysics2024

Iguratimod Alleviates Experimental Sjögren's Syndrome by Inhibiting NLRP3 Inflammasome Activation.

Qi Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.